Loading clinical trials...
Loading clinical trials...
A Randomized, Controlled Mutiple-center Clinical Research on the Treatment With Yangzhengxiaoji Capsule Combination Chemotherapy for III/IV Diffuse Large B Cell Lymphoma
Conditions
Interventions
Yangzhengxiaoji capsule combined with CHOP regimen
CHOP regimen
Locations
1
China
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Start Date
September 1, 2012
Primary Completion Date
September 1, 2016
Completion Date
September 1, 2018
Last Updated
December 30, 2015
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
NCT06352242
Lead Sponsor
Mingzhi Zhang
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions